Assignee
MAPI PHARMA LTD
IL·23 granted patents·5 pending applications·48 citations·filing 2011–2025
Top patents by PatentIndex Score
28 records- 0191US11931357B2Depot systems comprising Cariprazine or salts thereofMAPI PHARMA LTD·Filed 2023·Granted Mar 19, 2024·2 cites·18 claims
- 0291US9006188B2Co-crystals of dapagliflozinMAPI PHARMA LTD·Filed 2014·Granted Apr 14, 2015·8 cites·15 claims
- 0390US11026908B2Extended release dosage forms of pregabalinMAPI PHARMA LTD·Filed 2017·Granted Jun 8, 2021·3 cites·10 claims
- 0490US9200114B2Random pentapolymer for treatment of autoimmune diseasesMAPI PHARMA LTD·Filed 2013·Granted Dec 1, 2015·8 cites·14 claims
- 0588US8377885B2Depot systems comprising glatiramer or pharmacologically acceptable salt thereofMAPI PHARMA LTD·Filed 2012·Granted Feb 19, 2013·14 cites·26 claims
- 0686USRE49251EDepot systems comprising glatiramer or pharmacologically acceptable salt thereofMAPI PHARMA LTD·Filed 2021·Granted Oct 18, 2022·1 cites·36 claims
- 0784US11865213B2Semaglutide depot systems and use thereofMAPI PHARMA LTD·Filed 2021·Granted Jan 9, 2024·1 cites·19 claims
- 0882US10493122B2Sublingual delivery of glatiramer acetateMAPI PHARMA LTD·Filed 2015·Granted Dec 3, 2019·5 cites·8 claims
- 0979US11471421B2Process for preparing microparticles containing glatiramer acetateMAPI PHARMA LTD·Filed 2017·Granted Oct 18, 2022·2 cites·19 claims
- 1077US12251380B2Depot systems comprising cariprazine or salts thereofMAPI PHARMA LTD·Filed 2024·Granted Mar 18, 2025·0 cites·20 claims
- 1177US11167003B2Methods for suppressing or alleviating primary or secondary progressive multiple sclerosis (PPMS or SPMS) using sustained release glatiramer depot systemsMAPI PHARMA LTD·Filed 2018·Granted Nov 9, 2021·3 cites·20 claims
- 1277US2025352607A1Glatiramer depot systems for treating progressive forms of multiple sclerosisMAPI PHARMA LTD·Filed 2025·Application pending·0 cites
- 1375USRE50301EDepot systems comprising glatiramer or pharmacologically acceptable salt thereofMAPI PHARMA LTD·Filed 2022·Granted Feb 18, 2025·0 cites·35 claims
- 1471US8975244B2Process and intermediates for the preparation of abiraterone acetateMAPI PHARMA LTD·Filed 2014·Granted Mar 10, 2015·1 cites·18 claims
- 1570US12343371B2Method for suppressing or alleviating primary or secondary progressive multiple sclerosis (PPMS or SPMS) using a sustained release depot formulation comprising glatiramer acetateMAPI PHARMA LTD·Filed 2021·Granted Jul 1, 2025·0 cites·17 claims
- 1670US2024148653A1Semaglutide depot systems and use thereofMAPI PHARMA LTD·Filed 2023·Application pending·0 cites
- 1769US9453024B2Polymorphs of darunavirMAPI PHARMA LTD·Filed 2014·Granted Sep 27, 2016·0 cites·3 claims
- 1868US2021260006A1Extended release dosage forms of pregabalinMAPI PHARMA LTD·Filed 2021·Application pending·0 cites
- 1961US12097292B2Process for preparing microparticles containing glatiramer acetateMAPI PHARMA LTD·Filed 2022·Granted Sep 24, 2024·0 cites·20 claims
- 2061US9994522B2Amorphous form of apremilastMAPI PHARMA LTD·Filed 2014·Granted Jun 12, 2018·0 cites·20 claims
- 2159US9102592B2Intermediate compounds and processes for the preparation of quinoline derivatives such as laquinimod sodiumMAPI PHARMA LTD·Filed 2014·Granted Aug 11, 2015·0 cites·4 claims
- 2257US12514908B2Semaglutide depot systems and use thereofMAPI PHARMA LTD·Filed 2022·Granted Jan 6, 2026·0 cites·15 claims
- 2351US2023256058A1Low burst-release liraglutide depot systemsMAPI PHARMA LTD·Filed 2021·Application pending·0 cites
- 2450US9096574B2Polymorphs of perampanelMAPI PHARMA LTD·Filed 2013·Granted Aug 4, 2015·0 cites·7 claims
- 2546US12370233B2Depot systems comprising glatiramer acetateMAPI PHARMA LTD·Filed 2017·Granted Jul 29, 2025·0 cites·12 claims
- 2641US10111867B2Process and intermediates for the preparation of perampanelMAPI PHARMA LTD·Filed 2015·Granted Oct 30, 2018·0 cites·21 claims
- 2738US2013046103A1Preparation of benzofurans and use thereof as synthetic intermediatesMAPI PHARMA LTD·Filed 2011·Application pending·0 cites
- 2835US9617241B2Intermediate compounds and process for the preparation of efinaconazoleMAPI PHARMA LTD·Filed 2015·Granted Apr 11, 2017·0 cites·19 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →